Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reena Halai

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
FEBS Letters|February 5, 2008
The three-dimensional structure of the analgesic alpha-conotoxin, RgIARichard J Clark, Norelle L Daly, Reena Halai, et al.
Immunology and Cell Biology|April 30, 2014
C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitmentDaniel E Croker, Reena Halai, Geraldine Kaeslin, et al.
Scientific Reports|December 15, 2018
Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signallingZoe V Schofield, Daniel Croker, Avril A B Robertson, et al.
European Journal of Pharmacology|December 3, 2014
Derivation of ligands for the complement C3a receptor from the C-terminus of C5aReena Halai, Meghan L Bellows-Peterson, Will Branchett, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Journal of Medicinal Chemistry|November 25, 2024
Novel Macrocyclic NLRP3 InhibitorsStefanie Mesch, Jonathan Shannon, David Miller, et al.
Nature|June 15, 2017
Corrigendum: Common genetic variation drives molecular heterogeneity in human iPSCsHelena Kilpinen, Angela Goncalves, Andreas Leha, et al.
Nature|May 11, 2017
Common genetic variation drives molecular heterogeneity in human iPSCsHelena Kilpinen, Angela Goncalves, Andreas Leha, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
FEBS Letters|February 5, 2008
The three-dimensional structure of the analgesic alpha-conotoxin, RgIARichard J Clark, Norelle L Daly, Reena Halai, et al.
Immunology and Cell Biology|April 30, 2014
C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitmentDaniel E Croker, Reena Halai, Geraldine Kaeslin, et al.
Scientific Reports|December 15, 2018
Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signallingZoe V Schofield, Daniel Croker, Avril A B Robertson, et al.
European Journal of Pharmacology|December 3, 2014
Derivation of ligands for the complement C3a receptor from the C-terminus of C5aReena Halai, Meghan L Bellows-Peterson, Will Branchett, et al.
Immunology and Cell Biology|April 26, 2016
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signallingDaniel E Croker, Peter N Monk, Reena Halai, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Journal of Medicinal Chemistry|November 25, 2024
Novel Macrocyclic NLRP3 InhibitorsStefanie Mesch, Jonathan Shannon, David Miller, et al.
Nature|June 15, 2017
Corrigendum: Common genetic variation drives molecular heterogeneity in human iPSCsHelena Kilpinen, Angela Goncalves, Andreas Leha, et al.
Nature|May 11, 2017
Common genetic variation drives molecular heterogeneity in human iPSCsHelena Kilpinen, Angela Goncalves, Andreas Leha, et al.
Pageof 2